Wellcome Trust plans spike in research spending

The UK's Wellcome Trust says it will pump up its research spending by 60 percent over the next five years as it ambitiously seeks a better understanding of diseases at a genetic level. The funding spike--to £4 billion-backs a range of research projects, including the Biobank project, which is seeking a greater understanding of genetics and environmental factors as well as the Case Control Consortium, which hunts for genes involved in disease.

"One of our priorities is to increase our understanding of common human diseases at the genetic level," Wellcome chief Dr Mark Walport told the BBC. "Developments in technology have meant we can now do this kind of science on a scale that we've not been able to before."

 

- see this release
- read the article from the BBC

ALSO: President Bush's new budget is keeping the NIH's funding at an even level, a fact that quickly aroused protests from groups that have been harshly critical of the long-term effects of flat-line research budgets. Report

Related Articles:
Research group mapping 1,000 genomes. Report
Cells prompted to "eat" Huntington proteins. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.